Alpha Cognition Inc. Share Price

Alpha Cognition Inc. Share Price

NASDAQ: ACOG | Micro Cap
$8.01
+$0.12 (1.46%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Alpha Cognition Inc. Stock Performance

Open
$7.94
Prev. Close
$7.89
Circuit Range
N/A
Day Range
$7.81 - $8.01
Year Range
$4.51 - $9.93
Volume
11,076
Average Traded
$7.92

Alpha Cognition Inc. Share Price Today

As of 18 November 2026, Alpha Cognition Inc.'s share price is $8.01. The stock opened at $7.94, compared to its previous close of $7.89. During today's trading session, Alpha Cognition Inc.'s share price traded between $7.81 and $8.01, with an average price of $7.91. Over the past 52 weeks, the stock has recorded a high of $9.93 and a low of $4.51. In terms of performance, Alpha Cognition Inc.'s share price has risen by 34.17% over the last six months and is up 35.53% on a year-on-year basis.

Alpha Cognition Inc. Share Price Chart

Line chart of the Alpha Cognition Inc. price trend over the selected period. The price rose overall, ranging from 7.81 to 8.01, ending at 7.94.
$7.81$8.01
L
Show Current Price
H

Alpha Cognition Inc. Stock Fundamentals & Key Indicators

Market Cap
$141.62M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.06
Revenue (TTM)
$10.22B
Return On Equity (TTM)
-44.26%
Profit Margin
-202.25%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-11.08%

Alpha Cognition Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$2.79$3.53$6.09$7.78
Net Profit-$6.86-$6.48-$8.79-$7.62
Net Profit Margin-245.88%-183.57%-144.33%-97.94%
Income ChangeN/A5.54%-35.65%13.31%

Alpha Cognition Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$10.22
Net Profit-$14.79-$20.67
Net Profit MarginN/A-202.25%
Income ChangeN/A-39.76%

About Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Alpha Cognition Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.70
$7.95
-9.56%
Oct 2026
$8.63
$8.79
-2.77%
Sep 2026
$9.22
$9.04
-7.14%
Aug 2026
$8.30
$9.73
+18.29%
Jul 2026
$7.78
$8.23
+13.67%
Jun 2026
$6.17
$7.24
+21.27%
May 2026
$6.02
$5.97
-2.93%
Apr 2026
$5.56
$6.15
+13.36%
Mar 2026
$5.71
$5.42
-9.58%
Feb 2026
$5.04
$6.00
+17.88%
Jan 2026
$6.50
$5.09
-22.35%
Dec 2025
$5.94
$6.55
+10.91%

ACOG Share Price FAQs